Join the Vaccination and Prophlaxis group to help and get support from people like you.
Vaccination and Prophlaxis News (Page 12)
Vaccination of 27- to 45-Year-Olds Against HPV Is Less Cost-Effective
TUESDAY, Nov. 26, 2024 – Vaccination of 27- to 45-year-olds ("mid-adults") against human papillomavirus (HPV) is less cost-effective than vaccination of younger persons (aged 9 to 26 years),...
COVID-19, Flu, RSV Vaccine Coverage Low for Adults in 2024 to 2025 Season
MONDAY, Nov. 25, 2024 – COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025), according to research...
Flu, COVID Vaccination Rates Remain Low as Winter Nears
FRIDAY, Nov. 22, 2024 – Worn down by pandemic-era vaccine overload, many Americans are ignoring pleas by health officials to get immunized against the flu and COVID-19, new data shows. According to...
Global Coverage With Measles Vaccine Declined During COVID-19
MONDAY, Nov. 18, 2024 – Global coverage with measles vaccination declined during the COVID-19 pandemic, and estimated measles cases increased 20 percent worldwide from 2022 to 2023, according to...
President-Elect Trump Nominates Robert F. Kennedy Jr. to Lead HHS
THURSDAY, Nov. 14, 2024 – President-elect Donald Trump has chosen Robert F. Kennedy Jr. to head the U.S. Department of Health and Human Services. The department encompasses numerous key agencies,...
Trump Picks Vaccine Skeptic Robert F. Kennedy Jr. to Lead Health & Human Services
THURSDAY, Nov. 14, 2024 – In a move guaranteed to alarm many, President-elect Donald Trump has chosen Robert F. Kennedy Jr., a vocal opponent of vaccines and other tenets of mainstream health care,...
Chlamydia Vaccine Shows Early Promise in Mice
FRIDAY, Nov. 15, 2024 – An experimental vaccine has shown promise in protecting against the sexually transmitted disease chlamydia, researchers report. Lab mice given the vaccine were able to...
Falling Vaccination Rates Brings Spikes in Measles Worldwide
FRIDAY, Nov. 15, 2024 – Waning vaccine coverage has fueled a 20% spike in measles cases worldwide, with 10.3 million people struck by the preventable illness in 2023, health officials reported...
New Therapeutic Vaccine Gives Hope Against an Aggressive Breast Cancer
THURSDAY, Nov. 14, 2024 – An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests. The vaccine appears to...
Neoantigen DNA Vaccines Safe, Induce Response in Triple-Negative Breast Cancer
THURSDAY, Nov. 14, 2024 – Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with triple-negative breast cancer, according to a study published...
Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu Shots
FRIDAY, Nov. 8, 2024 – Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines, according to a study published online Nov. 6 in JAMA...
U.K. Reports First Cluster Outside of Africa of New Mpox Variant
THURSDAY, Nov. 7, 2024 – Four cases of the more infectious variant of mpox have been reported in the U.K., making it the first cluster of infections that have surfaced outside of Africa. British...
COVID Vaccine Mistrust Levels Aren't Budging, Study Finds
WEDNESDAY, Nov. 6, 2024 – More than a third of Americans continue to express mistrust in the science behind COVID vaccines, a new study finds. This level of mistrust has remained relatively...
Mpox Spread in Congo May Be Slowing
TUESDAY, Nov. 5, 2024 – In an early sign that the mpox outbreak in Africa might be ebbing, some health officials report that case counts seem to be stabilizing in the Congo, the epicenter of the...
In a National First, an Idaho Health Department Is Refusing to Give COVID Vaccines
MONDAY, Nov. 4, 2024 – In what may be a first for the United States, a regional public health department in Idaho will no longer provide COVID-19 vaccines, following a close vote by its board. “I’m n...